Second line treatment for relapsed chronic lymphocytic leukemia. Hematology Meeting Reports, [S. l.], v. 1, n. 7, 2009. DOI: 10.4081/hmr.v1i7.630. Disponível em: https://journals.pagepress.org/hmr/article/view/630. Acesso em: 8 aug. 2025.